Cincera Therapeutics

Quality over quantity

Cincera’s novel and differentiated approach to treating inflammatory and fibrotic conditions is derived from the academic research of our scientific co-founders and involves blocking a key enzymatic target in a lipid metabolism pathway. The inhibition of this enzyme not only blocks the formation of damaging pro-inflammatory and pro-fibrotic biolipids, but concomitantly leads to the accumulation of beneficial anti-inflammatory and anti-fibrotic biolipids in peripheral tissues.

This unique mechanism of action seeks to improve the quality rather than the quantity of lipids deposited in tissues in order to drive therapeutic benefit.

cinceratx.com

Cincera Therapeutics